Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dryvax Dose Response in Previously Vaccinated Adults
NCT00032708Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2004
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of dryvax in smallpox, sponsored by National Institute of Allergy and Infectious Diseases. Started Apr 2004; status: completed.
02
Drugs
dryvax
03
Conditions
smallpox
Beyond the preview
Go deeper on NCT00032708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00032708.